BNP Paribas Asset Management
IONS icon

BNP Paribas Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

BNP Paribas Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2M Sell
734,219
-173,314
-19% -$13M 0.06% 303
2026
Q1 		$68.1M Sell
907,533
-445,304
-33% -$35.1M 0.08% 245
2025
Q4 		$107M Buy
1,352,837
+293,116
+28% +$22.1M 0.12% 156
2025
Q3 		$69.3M Sell
1,059,721
-291,158
-22% -$14.2M 0.18% 120
2025
Q2 		$53.4M Buy
1,350,879
+154,487
+13% +$5.06M 0.13% 160
2025
Q1 		$36.1M Buy
1,196,392
+116,051
+11% +$3.8M 0.1% 216
2024
Q4 		$37.8M Buy
1,080,341
+300,620
+39% +$11.2M 0.09% 228
2024
Q3 		$31.2M Sell
779,721
-1,032
-0.1% -$48K 0.08% 242
2024
Q2 		$37.2M Buy
780,753
+2,160
+0.3% +$88.6K 0.1% 215
2024
Q1 		$33.8M Buy
778,593
+438,926
+129% +$20.9M 0.09% 235
2023
Q4 		$17.2M Buy
+339,667
New +$16.3M 0.05% 322
2019
Q4 		– Sell
-3,593
Closed -$215K – 843
2019
Q3 		$215K Hold
3,593
– – ﹤0.01% 827
2019
Q2 		$231K Buy
+3,593
New +$254K ﹤0.01% 867
2015
Q1 		– Sell
-3,692
Closed -$228K – 1060
2014
Q4 		$228K Buy
+3,692
New +$182K ﹤0.01% 932

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management's IONS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 19% in Q2 2026, selling an estimated $13M and leaving 734,219 shares worth $58.2M. The position accounts for 0.06% of the portfolio, ranked #303.

BNP Paribas Asset Management first reported a position in IONS in Q4 2014 and has held it in 14 quarters since. The position peaked at $107M in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • BNP Paribas Asset Management held 734,219 shares of Ionis Pharmaceuticals worth $58.2M as of Q2 2026.
  • BNP Paribas Asset Management sold 173,314 Ionis Pharmaceuticals shares in Q2 2026, an estimated $13M.
  • Ionis Pharmaceuticals made up 0.06% of BNP Paribas Asset Management's portfolio in Q2 2026, its #303 holding.
  • BNP Paribas Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 14 quarters since.
  • BNP Paribas Asset Management's Ionis Pharmaceuticals position peaked at $107M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.